Home

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF)

1.4800
-0.0700 (-4.52%)

Can-Fite Biopharma Ltd is a biopharmaceutical company that focuses on the development of innovative therapies for the treatment of cancer and other serious diseases

The company leverages its proprietary drug development platform to create targeted molecular medicines, which are designed to treat conditions such as psoriasis, liver disease, and various types of cancer. Can-Fite is dedicated to advancing its clinical trials and bringing promising therapies to market, with an emphasis on improving patient outcomes and addressing unmet medical needs in the pharmaceutical landscape.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Can-Fite Biopharma Ltd Sponsored ADR (Israel) publicly traded?
Yes, Can-Fite Biopharma Ltd Sponsored ADR (Israel) is publicly traded.
What exchange does Can-Fite Biopharma Ltd Sponsored ADR (Israel) trade on?
Can-Fite Biopharma Ltd Sponsored ADR (Israel) trades on the New York Stock Exchange
What is the ticker symbol for Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The ticker symbol for Can-Fite Biopharma Ltd Sponsored ADR (Israel) is CANF on the New York Stock Exchange
What is the current price of Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The current price of Can-Fite Biopharma Ltd Sponsored ADR (Israel) is 1.480
When was Can-Fite Biopharma Ltd Sponsored ADR (Israel) last traded?
The last trade of Can-Fite Biopharma Ltd Sponsored ADR (Israel) was at 8:00 pm EST on January 31st, 2025
What is the market capitalization of Can-Fite Biopharma Ltd Sponsored ADR (Israel)?
The market capitalization of Can-Fite Biopharma Ltd Sponsored ADR (Israel) is 763.30M
How many shares of Can-Fite Biopharma Ltd Sponsored ADR (Israel) are outstanding?
Can-Fite Biopharma Ltd Sponsored ADR (Israel) has 515.75M shares outstanding.